Abstract | The cardiovascular benefits of physical activity are indisputable. Nevertheless, growing evidence suggests that both atrial fibrillation and right ventricular arrhythmia can be caused by intense exercise in some individuals. Exercise-induced atrial fibrillation is most commonly diagnosed in middle-aged, otherwise healthy men who have been engaged in endurance training for >10 years, and is mediated by atrial dilatation, parasympathetic enhancement, and possibly atrial fibrosis. Cardiac ablation is evolving as a first-line tool for athletes with exercise-induced arrhythmia who are eager to remain active. The relationship between physical activity and right ventricular arrhythmia is complex and involves genetic and physical factors that, in a few athletes, eventually lead to right ventricular dilatation, followed by subsequent myocardial fibrosis and lethal ventricular arrhythmias. Sinus bradycardia and atrioventricular conduction blocks are common in athletes, most of whom remain asymptomatic, although incomplete reversibility has been shown after exercise cessation. In this Review, we summarize the evidence supporting the existence of exercise-induced arrhythmias and discuss the specific considerations for the clinical management of these patients.
Regular physical activity of moderate-to-vigorous intensity should be encouraged in all healthy individuals and most patients with cardiovascular conditions owing to its beneficial effects on lowering risk factor burden, improving wellness, and reducing mortality 1 . Although the benefits of exercise have been scientifically proven and are well-established, early studies that reported an increase in sudden cardiac death during, or shortly after, intense physical activity led researchers to question whether vigorous exercise was harmful 2 . Underlying cardiac abnormalities, either congenital or acquired, were later found to be present in most athletes who died suddenly [3] [4] [5] . Therefore, exercise was considered a trigger for ventricular arrhythmias and sudden death, paving the way for preparticipation screening programmes aimed at identifying underlying cardiac conditions 6, 7 . Results from studies performed in the past 2 decades provide evidence to support the premise that strenuous physical activity is not only able to trigger cardiac events, but can also promote the development of cardio vascular disease in individuals with no previous cardio vascular abnormalities [8] [9] [10] [11] . Most of this research has focused on the identification of arrhythmias originating in the atrium or the right ventricle. Specifically, the role of exercise in the development of atrial fibrillation (AF) has been acknowledged 12 . Conversely, the data supporting an involvement of the right ventricle in the pathogenesis of potentially lethal ventricular arrhythmias are scarce. One large report has suggested that extreme forms of exercise might paradoxically increase atherosclerotic complications 11 . Two consequences of exercise-induced arrhythmias underscore the importance of these conditions as publichealth concerns. First, the lifestyles of young athletes are generally seen as a hallmark of a healthy way of life and, for most individuals, an example to be followed. Public confusion and uncertainty surrounding the diagnosis of cardiac arrhythmia in young athletes, or reports of young athletes dying suddenly during sporting events has a negative effect on the impression of exercise among society. If not properly addressed, this issue might result in overall reduced physical activity and a subsequent rise in the burden of cardiovascular disease. Second, most exercise-induced heart conditions are diagnosed in individuals engaged in vigorous physical activities. Considering that the number of individuals under taking intense forms of exercise has been steadily increasing for the past 20 years 13 , the number of individuals affected by exercise-induced arrhythmias could also progressively increase over the next decade. Therefore, why and how these apparently paradoxical effects of exercise fit into actual knowledge, and how they should be approached, are critical for all health-care personnel and policy makers to understand. In this Review, we present the evidence supporting the existence of exercise-induced arrhythmias and the underlying mechanisms, and discuss the specific considerations for the clinical management of these patients.
Atrial arrhythmias in athletes AF is the most common sustained arrhythmia in the general population. AF is characterized by the loss of synchronous atrial electrical activity and contraction, which results in increased risk of thromboembolism and heart failure, impaired quality of life, and a twofold higher adjusted risk of death 14 . Hypertension and structural heart disease are two of the most frequent causes of AF in the general population. Cardiovascular abnormalities are absent in up to 10% of patients with AF; risk factors for the development of AF in these patients include obstructive sleep apnoea, obesity, and intense exercise 15 . The first evidence linking exercise and AF was first reported in the late 1990s 8, 9 , prompting much debate among researchers, with one side drawing attention to the growing core of evidence supporting this link, and the other highlighting the potential biases and inconsistences in the data 13, 16 . The rationale behind these debates are the seemingly conflicting results derived from studies with heterogeneous methodology and analytical approaches, an intrinsic limitation of the retrospective nature of most studies. Central to this limitation is the considerable variability in the ways in which physical activity has been quantified. Physical activity is intuitive, but difficult to quantify; several approaches have been taken to assess physical activity 17 , including evaluation of well-trained athletes, questionnaires, or objective assessment of cardiovascular fitness
. Remarkably, with an increase in published studies on this topic, the association between physical activity and AF becomes more consistent across all these methods (FIG. 1) .
Exercise-induced AF
The first association made between exercise and AF came from studies that found an unexpected overrepresentation of endurance athletes in a lone AF cohort 9 and an increased risk of AF in veteran orienteer ing runners 8 . Subsequent studies were performed in elite athletes who had been engaged in marathon running 18 , cycling 19 , or cross-country skiing 20, 21 , which showed that they were at a fourfold to 15-fold increased risk of AF compared with the general, sedentary population. Aizer and colleagues provided the first evidence that this associ ation was not limited to elite athletes, but also affected the most active individuals in the general popu lation 22 . In their study, jogging for 5-7 days per week increased the risk of AF by 1.7-fold in individuals aged <50 years. Subsequent larger studies provided further confirmation of this association among the general popu lation. In a study that included >300,000 Norwegian men and women, men engaged in regular, intensive physical activity (defined as participation in hard training or sporting competitions, several times per week) were at a threefold increased risk of being prescribed flecainide (a surrogate for AF diagnosis) 23 . Drca and colleagues found that Swedish men who vigorously exercised >5 h per week at the age of 30 years had a 1.2-fold increased risk of being diagnosed with AF later in life 24 . To date, the largest of such studies was conducted in >1.1 million men undergoing mandatory conscription in Sweden during a 23-year period; these men were followed up for an average of 26 years 25 . Better cardio vascular fitness -objectively assessed using a bicycle ergometer test -correlated with a progressive increase in the incidence of AF. For example, individuals categor ized in the quintile with the highest fitness had 1.3-fold higher risk of AF than the quintile who were least fit 25 . In general, a low comorbidity burden is common in these aforementioned cohorts.
Conversely, several studies have not shown this associ ation, or have even found that physical activity protects against the development of AF. Moderate levels of exercise in individuals with specific cardiovascular conditions are thought to decrease arrhythmic risk. At the epidemiological level, objectively assessed
Key points
• A growing body of evidence suggests that both atrial fibrillation (AF) and right ventricular arrhythmia can be the result of intense exercise among highly trained athletes • The risk of AF conferred by exercise progressively increases with the intensity of exercise • Parasympathetic tone enhancement and atrial structural remodelling (that is, atrial dilatation and fibrosis) are progressively being recognized as contributors to increased exercise-induced proarrhythmogenic risk • The most appropriate approach for treating exercise-induced AF remains unknown • The evidence for a pure exercise-induced arrhythmogenic right ventricular cardiomyopathy (ARVC) is limited, but several studies have indicated that regular exercise is an important promoter of ARVC progression • For athletes who fulfil ARVC criteria, guidelines published by scientific societies prohibit competitive sports and encourage avoidance of high-intensity dynamic sports in general Box 1 | Methods used to estimate exercise Use of physical activity questionnaires [22] [23] [24] 38 • Enables an estimate of current, past, and lifetime physical activity • Subject to recall bias (self-reported) • Validated questionnaires preferred 8, [18] [19] [20] [21] • Assumes very hard training for long periods of time (lifetime accumulated) • Subject to selection bias Objective assessment of physical activity 25, 26, 52 • Treadmill test commonly used • Moderate correlation to amount of exercise practised • Estimates current fitness only (not lifetime) physical fitness was negatively correlated with the incidence of AF in a cohort of >64,000 individuals of middle-to-advanced age with a high burden of cardiovascular risk factors and cardiomyopathies 26 . Estimated physical activity in older individuals has been found to reduce 27 or have no effect 28 on the incidence of AF. Clinical trials have consistently reported that moderate doses of physical activity might be of therapeutic value to patients who have already been diagnosed with AF. Physical activity is an important component in the multidimensional secondary prevention approach aimed at controlling risk factors for AF, particularly in patients with obesity presenting with one or more risk factors 29 , and seem as important in preventing AF recurrence as the use of antiarrhythmic drugs. These benefits might be, at least in part, attributable to better control of classic risk factors for AF, including hypertension or diabetes mellitus 29 . Remarkably, weight loss after regular training might contribute to AF burden reduction 30 . Nevertheless, the effects of exercise on improving physical fitness are additive to those of weight loss, and among patients with obesity and AF, those who are less fit at baseline or present with lower fitness improvement after the completion of a training programme are at highest risk of AF recurrence, independent of the change in weight 31 . An improvement in AF control can be observed early after initiation of a training programme. In a second ary prevention trial, AF burden was almost halved in patients aged 60 years on average who were randomly assigned to aerobic interval training three times per week for 12 weeks compared with those receiving usual care 32 . Furthermore, in patients with diastolic heart failure, physical training improved diastolic function and reversed atrial remodelling 33 . In addition to other factors discussed later, these results suggest that exercise increases the risk of AF in apparently healthy individ uals, but prevents AF in those individuals presenting with other risk factors and, therefore, a higher basal risk.
Cohorts of athletes
Most of the aforementioned studies have evaluated leisure-based physical activity. Occupational physical activ ity has been repeatedly shown not to be associated with an increased risk of AF 34, 35 . Low occupational physical intensity in most individuals, and predominant strength-based workload in those individuals with high-intensity physical activity (in contrast to endurance training in athletes), probably accounts for the lack of an association between occupational physical activity and AF.
Exercise-induced atrial flutter AF and atrial flutter share some basic pathophysiological and clinical features. Whereas much research has linked physical activity with increased risk of AF, the relationship between atrial flutter and physical activity is less established. Long-term endurance sportsmen were over-represented in a cohort of patients with lone atrial flutter 36 , yielding an odds ratio of 5.3 (95% CI 2.10-13.53). The increased risk of arrhythmia conferred by exercise occurs earlier and more intensely for atrial flutter than for AF 37 . Analyses of large cohorts 21, 24, 25, 27, 28, 38 and a study in veteran elite cyclists 19 indistinctly defined AF and atrial flutter as outcomes, and did not provide separate results for each arrhythmia 24, 38 . Overall, the risk of atrial flutter is also considered to be increased as a consequence of physical activity; nevertheless, the influence of AF on overall atrial arrhythmia burden is considered to be higher owing to its larger relative contribution to disease burden.
Identifying the risk of AF
Current evidence from global studies suggests that the relationship between exercise and AF is complex and probably relies on the balance between baseline cardiovascular risk factors; the type, intensity, and duration of physical activity; and individual susceptibility. Published studies largely have not separated each of these factors, thereby accounting, at least in part, for the apparently conflicting conclusions of these investigations
.
An association between AF and physical activity has been reported in men 18, 22, 24, 25, 39 , but the effects of exercise in women remain controversial (FIG. 2a) . In a retro spective study, Drca and colleagues found that self-reported sporting activity in women aged 30 years did not predict AF incidence 38 , in contrast to their findings in men 24 . Two large studies that confirmed an association between exercise and AF also provided sex-based subanalyses 21, 23 . In a study by Andersen and colleagues, the strength of the association was similar for men and women, although the association was not significant in women, probably because of the smaller sample size of the female sub cohort 21 . In a larger, Norwegian cohort involving >140,000 men and >160,000 women, physical activity was associated with a threefold increase in the incidence of AF in men, but not in women 23 . In a cohort involving >1,400 women, >40 years of intense endurance training was associated with a nonsignificant (P = 0.07) twofold increased risk of AF 40 . Although a similar U-shaped relation ship between physical activity levels and risk of AF in both men and women was identified in a study published in 2016, formal statistical analyses were not Nature Reviews | Cardiology
Degree of evidence
Atrial fibrillation/flutter 144 142 143 Figure 1 | Evidence assessing the association between physical activity and risk of atrial fibrillation (AF). Positive studies (those with a finding that physical activity significantly increases the risk of AF/atrial flutter) are represented with a green circle containing the reference to the study; negative studies (those that rule out a significant proarrhythmic effect of exercise) are represented with a red circle. Studies exclusively analysing women are not shown. CC, case-control.
reported for women alone 35 . Conversely, in agreement with findings in men, physical activity was protective against AF in two cohorts of postmenopausal women 41 and women aged 60-70 years 42 who had a high burden of cardiovascular risk factors. Overall, evidence to reliably affirm a proarrhythmogenic effect of exercise in women is inadequate 43 . Sex-related physiological differences, attenuated exercise-induced cardiac remodelling, or a lower exercise intensity in women probably contribute to the lack of an evident exercise-induced increased risk of AF 44 . The risk of AF conferred by exercise progressively increases with the intensity of exercise (FIG. 2b) . Risk of AF in competitive athletes (relative risk [RR] 4-15) is higher than in studies conducted in active individuals in the general population (RR 1.2-2.0 in the most active individuals). The risk conferred by exercise progressively increased with jogging intensity and duration in a cohort of healthy, middle-aged, male physicians 22 . A gradient of risk exists even within highly trained individuals. In a cohort of >50,000 individuals participating in a 90 km cross-country skiing race, those who performed better (with a finish time of <2.4-fold the winning time) were at a 1.2-fold higher risk of AF over a 9-year follow-up period than those who took longer to finish the race 21 . The type of exercise that yields the most prominent proarrhythmogenic effect has not been systematically studied. To date, most small studies confirming an association between physical activity and AF have been conducted for endurance sports (marathon running, cycling, and cross-country skiing) [18] [19] [20] [21] 45 or mixed sports (handball) 46 . Jogging, but not other sporting activities, increased the risk of AF in a large study 22 . A subanalysis of the FUTURE study 47 in patients with lone AF reported an odds ratio of 9 for AF in individ uals involved in endurance sports compared with those involved in team sports. To date, an association between increased incidence of AF and strength-based sports has not been shown in any studies. Indeed, in a large, populationbased, Swedish study, cardiovascular fitness assessed in a bicycle ergometer test, but not muscu lar strength tested using a hand dynamometer, was associated with AF incidence during follow-up 25 . The incidence of AF progressively increases with the number of years of active sports participation. Most studies show that athletes diagnosed with AF have been engaged in regular exercise training for >10 years (FIG. 2c) . A study published in 2014 found that the risk of AF increases after 20 years of active sport participation, and progressively increases with a longer duration of exercise 37 . In patients with lone AF in the FUTURE study 15 , lifetime accumulated physical activity was the strongest predictor of AF prevalence, above ongoing exercise and physical activity density (hours of physical activity per year). In this study, >2,000 h of lifetime vigorous exercise was associated with an odds ratio of ~4 for AF.
Exercise-induced AF commonly affects middle-aged individuals. Total accumulated lifetime physical activity is a critical factor in the development of AF 15, 37 , thus explaining why AF is infrequently diagnosed in young individuals 48 . A link between physical activity and an increased risk of AF has been consistently confirmed when physical activity was assessed in middle-aged individ uals, but nonexistent when assessed in later stages of life (FIG. 2d) . A substudy of the Physicians Health Study found that physical activity before, but not after, the age of 50 years predicted incidence of AF 22 . This 50-year threshold hypothesis was supported by data from a subanalysis performed by Morseth and colleagues 35 . Further supporting this notion, Drca and colleagues found that participation in sporting activity at age 30 years, but not at 60 years, predicted a higher incidence of AF in the elderly 24 . Two factors are likely to explain the lack of a proarrhythmogenic effect of exercise in the elderly: first, physical activity in aged individuals is likely to be of a lower intensity than in young or middle-aged individuals and, therefore, is associated with lower haemodynamic load 49 ; and second, the accumulation of risk factors in the elderly might override the potential deleterious effects of intense physical activity 24, 27, 50 . Nevertheless, variability remains within this high-risk population of seemingly healthy middle-aged individ uals who have participated in intense endurance exercise for a long duration. AF affects only a limited number of athletes, in whom genetic background is likely to contribute to increased risk. A small subset of highly trained athletes presented with atrial dilatation and dysfunction, which lead to increased atrial wall stretch during physical activity that might increase the risk of maladaptive remodelling in the atrium 51 . However, no individual susceptibility factors have been found for exercise-induced AF.
Overall, an increasing body of evidence supports a U-shaped relationship between total amount of physical activity and incidence of AF 15, 35, 52 , largely shaped by the presence of risk factors, exercise intensity, and genetic background and variability (FIG. 3a) . According to this hypothesis, both exercise duration (FIG. 3b) and intensity (FIG. 3c, d) resulted in a U-shaped dose-response curve in terms of risk of AF. Low-to-moderate bouts of physical activity reduce the risk of AF, particularly in those individuals with other risk factors (for example, heart failure, hypertension, and ageing), whereas increasing doses might elevate the risk.
Pathophysiology of exercise-induced AF
The mechanisms by which a previously healthy atrium develops an arrhythmogenic substrate after several years of physical activity are likely to be multi factorial and involve physiological (athlete's heart), but also pathological, components of exercise-induced cardiac remodelling (FIG. 4) . Notably, whereas some data have been obtained from athletes, most pathological insights have been acquired from animal models and, until they are confirmed in humans, caution is warranted when translating these conclusions.
Sinus bradycardia and delayed atrioventricular conduction are well-known features of the athlete's heart, but the underlying mechanisms of these conditions remain controversial. Whereas some studies claim a critical role of primary electrical remodelling, classic theories consider parasympathetic tone enhancement as a central mechanism in athlete's bradycardia 53, 54 . Notably, parasympathetic tone also shortens the atrial refractory period, facili tating re-entry formation and AF establishment 55 . Therefore, parasympathetic tone enhancement is likely to be a contributor to exercise-induced pathology. Indeed, AF events in parasympathetic-predominant circumstances (for example, sleeping or after meals) are common in trained individuals 9, 56 . In nonprofessional athletes participating in a 10-mile race, those with the heaviest lifetime-accumulated workload presented with a higher prevalence of AF and greater parasympathetic enhancement than less-trained athletes 57 . Furthermore, autonomic tone imbalance was a critical contrib utor to exercise-induced AF substrate in an endurance, treadmill-trained, animal model 58 . Atrial structural remodelling, namely atrial dilatation and fibrosis, is progressively being recognized as a contributor to increased exercise-induced proarrhythmogenic risk. Atrial dilatation is considered a physiological response to exercise, but at the same time increases the critical myocardial mass needed to establish the develop ment AF 59 . Indeed, atrial dilatation frequently contributes to AF establishment in hypertension or heart failure, and to AF self-perpetuation 60 . To date, no robust evidence is available proving that atrial dilatation in athletes is structurally different from that in pathological settings. Baldesberger et al. 19 Molina et al. 18 Elosua et al. 141 Aizer et al. 22 Drca et al. 24 Karjalainen et al. 8 Karjalainen et al. 8 Mont et al. Mozzafarian et al. 27 Drca et al. 38 Andersen et al. 21 Thelle et al. 23 Myrstad et al. 40 Everett et al. 42 Azarbal et al. 41 Andersen et al. 21 Andersen et al. 25 Thelle et al. 23 Drca et al. 24 Bapat et al. 28 Aizer et al. 22 Negative studies
Positive studies
Mozzafarian et al. 27 Bapat et al. 28 Drca et al. 24 Qureshi et al. 26 Huxley et al. 148 Khan et al. 52 Morseth et al. 35 Andersen et al. 21 Thelle et al. 23 Drca et al. 24 Andersen et al. Myrstad et al. 37 Collagen fibres interspersed between cardiomyocytes impede normal electrical conduction in the atrium and promote heterogeneous electrical conduction and reentry formation. Fibrosis has become a structural hallmark of AF pathology 61 . Exercise-induced atrial fibrosis was first described in an intense-exercise animal model. A group of rats were trained on a treadmill at high intensity for 16 weeks and tested for AF inducibility at the end of the experimental protocol 58, 62 . Trained rats were more readily inducible than their sedentary littermates, and AF inducibility was associated with a ~60% increase in atrial fibrosis 58, 62 . Similar results were later shown in a swim-trained mouse model 63 . Evidence for atrial fibrosis has not been found in athletes yet, but is supported by some indirect data. Veteran athletes present with higher levels of profibrotic markers such as the plasmatic fibrosis turnover markers carboxyterminal propeptide of collagen type I (PICP), carboxy terminal telo peptide of collagen type I (CITP), tissue inhib itor of matrix metallo proteinase type I (TIMP1; also known as metalloprotein ase inhibitor 1) 64 , galectin 3 (REF. 65 ), and certain circulating profibrotic microRNAs such as miR-21 (REF. 66 ). Endurance athletes show an accumulated physical activity-dependent P-wave prolongation 67 ; notably, P-wave duration does not correlate with atrial size in athletes 68 . Surgical atrial samples have shown that P-wave duration is associated with atrial fibrosis 69 . The mechanisms leading to collagen deposition in the atrium of athletes remain largely unknown. Repetitive exercise training has been suggested to promote structural damage 70 , which eventually leads to the formation of fibrosis. Animal studies have demonstrated that the renin-angiotensin-aldosterone system participates in exercise-induced fibrosis 71 , whereas others have proposed that exercise-induced hypertension could underlie the maladaptive atrial processes in some athletes 18, 72 ; however, current evidence does not support this notion 73 . Haemodynamic overload during strenuous exercise training might trigger mechanisms involved in myocardial fibrosis formation. Intense exercise increases atrial wall stretch 74 . Tumour necrosis factor mediates stretch-promoted local myocardial inflammation, and has a central role in exercise-induced fibrosis in a preclinical model 63 . Intense bouts of physical activity yield transient, duration-dependent, and intensity-dependent systemic inflammation that might also contribute to exercise-induced cardiac maladaptation. Interestingly, cardiac dysfunction following strenuous bouts of exercise correlates with systemic inflammation 75 . Overall, either systemic or local, acute bouts of exercise have been shown to cause myocardial inflammation and apoptosis in an animal model 76 . In athletes, the P-wave is transiently prolonged after completing a marathon; however, this effect cannot be fully explained by atrial dilatation -atrial inflammation and oedema are more likely explanations 77 . Environmental factors might also contribute to exercise-induced AF, although most of them remain speculative. Strenuous exercise prompts acute, transient abnormalities in immune response, including variable degrees of immunosuppression 78 . Although conflicting data have been published and limitations been claimed, several studies have found a higher incidence of upper respiratory tract infections in athletes 79, 80 . Infection with cardiotropic viruses has been linked with variable degrees of myocardial inflammation. Ventricular mid myocardial or subepicardial fibrotic patches are a characteristic sequela of myocarditis 81 ; atrial myocarditis often coexists with ventricular myocarditis 82 and is likely to cause atrial fibrosis. Interestingly, data from animal models suggest that exercise exacerbates deleterious consequences of infectious myocarditis 83 . Therefore, infection by cardiotropic viruses during postexercise immunosuppression might plausibly induce sub clinical myocarditis that, either exacerbated or not exacerbated by subsequent exercise, could contribute to atrial fibrosis formation.
Performance-enhancing drugs are used by some professional and amateur athletes, but their contribution to exercise-induced AF pathology remains speculative owing to the obscure nature of drug doping. Remarkably, almost 70% of veteran cyclists included in the study by Baldesberger and colleagues admitted to using performance-enhancing drugs, mainly amphetamines or anabolic steroids 19 . Case reports have provided the basis for a role of anabolic steroid use in the development of AF 84 . Chronic anabolic steroid administration has been associated with prolonged atrial electromechanical delay among professional bodybuilders 85 . However, contrary to this hypothesis, no reports exist showing an increased incidence of AF in disciplines associated with high-prevalence performance-enhancing drug use, such as bodybuilding and wrestling 86 . In addition to promoting a proarrhythmogenic substrate, repetitive exercise training might also trigger AF events. Whereas chronically elevated parasympathetic tone might have a role in AF promotion at rest 58 , increased sympathetic tone during physical exertion might also trigger AF events 56 . Haemodynamic overload during physical activity increases atrial wall stretch, which increases arrhythmogenicity through connexin inactiv ation and atrial conduction slowing 87, 88 . Atrial premature beats might act as AF triggers in the presence of a suitable substrate. The burden of premature atrial complexes is mildly increased in veteran athletes in some 57, 69 , but not all, studies 19 . The clinical relevance of exercise-induced atrial ectopic beats remains to be elucidated.
Clinical management of AF in athletes
The contribution of vigorous physical activity to the global incidence and prevalence of AF is unknown. Some studies suggest that exercise contributes to AF pathology in ~40% of patients with AF in the absence of other cardiovascular conditions (that is, lone AF) 9, 15 . Unfortunately, no effective tools are currently avail able to identify those athletes at a high risk of exercise-induced AF who would be candidates for primary prevention strategies. An early diagnosis upon clinical suspicion seems to be the only feasible approach to prevent AF progression 60 . A prolonged PQ interval has been associated with the development of exercise-induced AF 20, 46 , but the clinical use of this measure as a marker of risk of AF is hampered by its low predictive value.
Among athletes, AF is one of the most common causes of palpitations 89 , and is associated with an extensive symptomatology 56 and poor subjective health status 90 . AF events can present at rest or during exercise 9, 56 . Physical performance commonly decreases during AF episodes owing to the loss of atrial contribution to cardiac output. Of note, an unexplained decrease in physical performance might be the only clinical symptom of exercise-induced AF and should raise awareness of AF as a potential diagnosis. Conversely, some of the affected athletes will remain almost asymptomatic or present with minor symptoms that will not prevent them from competing at a high level 56 . Upon clinical suspicion of AF, efforts should be directed towards obtaining an electrocardiogram (ECG) during occurrence of symptoms, including a 12-lead ECG at rest, Holter ambulatory recordings, or implantable devices, if needed. Smartphone applications are an effective tool to quickly and easily obtain an ECG during short-term symptoms 91 ; nevertheless, expensive add-on hardware is required to obtain reliable single-lead ECG recordings. Treadmill stress tests might serve to uncover AF in athletes experiencing palpitations during physical activity. Athletes diagnosed with AF should be managed using contemporary methods and in a manner similar to . Even in the presence of an evident endurance training history, secondary causes of AF should always be ruled out, including (but not limited to) thyrotoxicosis, cardiomyopathies, or masked hypertension (FIG. 5) .
Although AF undeniably impairs quality of life and physical performance in affected athletes, whether these individuals have adverse survival prognosis and complication rates is unknown. Notably, the rate of stroke is higher in veteran athletes with AF than in athletes without AF, and is similar to the stroke rate in the comparable (nonathletic) AF population 90 . The stroke risk attributable to AF is higher in athletes than in nonathletes 92 , although the well-known decrease in atherosclerotic risk factors in active individuals is likely to justify the higher relative contribution of AF.
AF confers a 1.5-1.9-fold increased risk of death in the general population 93 . Data on mortality for athletes with AF are not yet available. Given that exerciseinduced AF mostly affects middle-aged individuals with a low comorbidity burden (lone AF), mortality should theoretically remain largely unaffected. In the absence of cardio vascular comorbidities such as hypertension or heart failure, the risk of cardiovascular complications is low 94, 95 . These data suggest that AF might not have a negative survival effect at diagnosis in the predominantly middle-aged cohort of athletes, but might have deleterious effects in later stages of life.
Therapeutic approach. The most appropriate approach for treating exercise-induced AF remains unknown, including whether specific considerations should be taken into account (FIG. 5) . In this regard, the anticoagulation strategy is critical and should follow the same recommendations as for the general population 12 (that is, in patients with nonvalvular AF with a CHA 2 DS 2 -VASc score ≥1 or for short-term pericardioversion or periablation periods).
Avoiding the aetiological factor (in this case, exercise) seems to be the common-sense approach, but robust and consistent evidence of benefit for this recommendation is lacking. A small subgroup of four athletes with AF showed significant improvement in symptoms after deconditioning (ceasing exercise) to the point at which they were able to reinitiate training 89 . Furthermore, Heidbuchel and colleagues found that athletes who abandoned training after an atrial flutter ablation developed less AF than those who continued exercising 96 . Results from a study using an animal model suggest that the atrial arrhythmogenic substrate regresses shortly after abandoning physical activity 58 .
In clinical practice, deconditioning is further jeopardized by individual, nonmedical factors. First, in our own experience, a substantial proportion of athletes with AF have an addiction to physical activity, which affects up to 5% of young university students living in the USA 97 . In a subgroup of these patients, addiction might lead to negative symptoms and even social isolation. Second, professional athletes might not be willing to retire owing to financial losses. Conversely, regular, moderate physical activity should be encouraged for its effects in improving quality of life in patients with AF 98 . Medical therapy should follow the general guidelines for patients with AF 12 , with particular attention to doping issues and their effect on cardiac performance. In general, an athlete will be willing to follow a rhythmcontrol strategy if they decide to remain in competitive sports. If class Ic antiarrhythmic drugs (for example, flecainide) are used, β-blockers or nondihydropyridine calcium channel blockers are also required to avoid rapid ventricu lar rate in the case of type Ic flutter. An exercise test is advisable before returning to regular training in those athletes employing a rate-control strategy or those who develop symptoms during exercise.
AF ablation has a central role in the treatment of young and middle-aged symptomatic patients. In this regard, ablation might be considered as first-line therapy in athletes with AF 12 . Treatment outcomes are similar in athletes undergoing AF ablation and other patients with AF but no concomitant cardiovascular conditions 99 , particu larly for endurance-trained athletes 100 . Symptomatic athletes who undergo AF ablation might be able to return to high-level sporting competition 101 .
Ventricular arrhythmias in athletes
Ventricular arrhythmias -mostly isolated ventricular premature beats -are common in athletes, but whether ventricular arrhythmia burden is higher in athletes than in sedentary individuals remains unclear 102, 103 . A common concern is whether athletes with ventricular Nature Reviews | Cardiology arrhythmias are at an increased risk of sudden death. Any excess of sudden cardiac death among athletes is considered to be related to underlying structural heart disease (such as hypertrophic cardiomyo pathy, arrythmogenic right ventricular cardiomyopathy (ARVC), and channelo pathies). In this regard, the more frequent and complex the identified ventricular arrhythmia (from frequent isolated ventricular premature beats to sustained ventricular arrhythmias), the higher the prevalence of an underlying cardiomyopathy 104 . ARVC is a hereditary cardiac condition predominantly affecting the right ventricle, and is most commonly caused by mutations in proteins involved in desmosome assembly. The pathophysiology of ARVC involves replacement of the myocardium with fibrofatty tissue, along with right ventricular (RV) dilatation and dysfunction. These factors are associated with an increased risk of ventricular tachycardia and fibrillation and, in some patients, symptoms of heart failure. Over the past few years, a link between ARVC and physical activity has been proposed. Strenuous physical activity has been suggested to contribute, either as a central aetiological factor or as a promoter of disease progression, to the pathology of ARVC. However, the evidence for this association is limited and, in some cases, controversial.
The ARVC continuum
In 2003, Heidbuchel and colleagues first reported on a group of well-trained endurance athletes who presented with complex symptomatic ventricular arrhythmias 10 or aborted sudden cardiac death that was likely to origin ate from a mildly dysfunctional right ven tricle 10, 105 . A subset of these athletes fulfilled criteria of a diagnosis of ARVC, but contrary to expectations, evidence of inheritance was lacking. The researchers speculated that endurance training had a central role as an aetiological factor in these patients, an assertion that was also supported by a lower-than-expected prevalence of ARVC-causing mutations 106 . Similarly, in the North American Multidisciplinary Study 107 , patients with ARVC without a desmosome mutation were more often competitive athletes. These findings have resulted in the concept of 'gene-elusive ARVC' . In a single-centre cohort study, patients with gene-elusive ARVC were more likely to be endurance athletes, and had a history of more intense physical activity than patients with desmosome mutations 108 . Whereas Heidbuchel and colleagues focused their analysis in a highly selected group of diseased individuals 10, 105 , studies that have assessed alternative methodological approaches with the use of unselected cohorts of athletes did not identify a deleterious effect of exercise in the right ventricle. Andersen and colleagues did not find increased diagnoses of ventricular tachycardia, ventricular fibrillation, or cardiac arrest in cross-country skiers participating in the Vasaloppet race 21 or in the male Swedish population undergoing conscription in a 23-year period 25 . However, these complex data need to be carefully interpreted. Patients with an underlying cardiomyopathy (that is, definite or probable ARVC) are usually excluded from competitive sport participation and, therefore, selection bias is a possibility in small sample studies. Moreover, the prevalence of exercise-induced ARVC-like cardiomyo pathy, if eventually confirmed, is likely to be low and largely influenced by individual susceptibility. We speculate that such a low prevalence would hamper the assessment of this condition in unselected or large cohorts with a limited statistical power to identify these small subpopulations 13 . Although the evidence for a pure exercise-induced, ARVC-like cardiomyopathy is limited, growing evidence suggests that regular exercise is an important factor that promotes ARVC progression. Desmosome mutation carriers engaged in regular vigorous physical activity present with an earlier clinical ARVC diagnosis 107 , increased ventricular arrhythmia incidence 107, 109 and greater RV structural and functional remodelling 107, 110 than their sedentary counterparts. Furthermore, bouts of strenuous exercise are a common trigger for sudden cardiac death in affected patients 4 .
Overall, these findings suggest, with different degrees of evidence, that exercise might cause and aggravate similar forms of ARVC. Whether these represent two extremes of a pathological and clinical continuum (FIG. 6) remains to be established.
Pathophysiology of gene-elusive ARVC
The identification of the mechanisms underlying maladaptive RV remodelling as a substrate for arrhythmias in athletes is complicated by the complex interaction of genetics and the dose of exercise. Data specifically focusing on exercise-induced, gene-elusive ARVC are scarce. Ventricular arrhythmias were more readily inducible in an electrophysiological study in intensively trained rats than in their sedentary littermates 62 . Selective RV dilatation and an increase in myocardial fibrosis (while absent in the left ventricle) was proposed to have a central role in exerciseinduced ventricular arrhythmogenesis 62 . Notably, no fatty replacement of the RV myocardium was observed.
Robust evidence for RV fibrosis in highly trained athletes is lacking. As previously mentioned, veteran athletes show an increase in markers of plasma fibrosis 64, 111 . Endomyocardial biopsies in athletes with ventricu lar arrhythmias have provided some insight into the arrhythmogenic substrate in humans. Dello Russo and colleagues observed fibrofatty replacement in five of 13 athletes and active myocarditis foci in seven of 13 athletes with symptomatic ventricular arrhythmias but no apparent structural heart disease 112 . Furthermore, fibrosis was found in three of eight patients with ventricular arrhythmias in the series by Heidbuchel and colleagues 10 . Late gadolinium enhancement is a promising technique to measure myocardial fibrosis noninvasively; however, the sensitivity of conventional magnetic reson ance techniques to detect diffuse fibrosis is low 113 . Several small cohort studies including unselected athletes have not identified RV fibrosis by means of late gadolinium-enhanced magnetic resonance [114] [115] [116] . Interestingly, although ischaemic and myocarditis fibrotic patches were found in a small subgroup of highly trained athletes 117, 118 , left ventricular (LV) ultrastructure remained preserved in most athletes 62, 114, 119 . Therefore, a central issue in these athletes with ventricular arrhythmias is the rather selective and specific effect on the right ventricle, with mild or no LV involvement 120 . Cardiac magnetic resonance (CMR) is the gold-standard technique for morphological and functional assessment of the right ventricle. Current evidence obtained through CMR imaging points to imbalanced remodelling of the right and left ventricles in highly trained individ uals, with disproportionate RV enlargement 114, 119 . Bouts of strenuous exercise can induce transient intensity-dependent and duration-dependent RV dilatation and dysfunction, whereas the left ventricle remains relatively preserved 119, 121 . La Gerche and colleagues provided remarkable insights into the mech anism of this selective RV effect by showing that right-left haemodynamic and morphological differences provoked a small (~14%) increase in LV wall stress during exercise, but a notable (~125%) increase in the right ventricle, leading to higher workload 115 . Notably, large, interindividual differences in RV adaptation exist that are not solely related to previous training 116 , but also to individual susceptibility 121 . As for exercise-induced AF, performance-enhancing substances have been postulated as aetiological factors for exercise-induced ventricular arrhythmias in a case report 122 , and their use should be queried in all affected athletes. Nevertheless, the contribution of these performance-enhancing substances to ventricular arrhythmias remains speculative.
Clinical management of RV arrhythmias
Ventricular arrhythmias in athletes require dedicated management by an experienced cardiologist or specialized sport physician (FIG. 7) . The first step in diagnosis involves ruling out an underlying cardiomyopathy. In the absence of cardiomyopathy, ablation procedures might be beneficial for treating idiopathic ventricular arrhythmias (that is, outflow tract and fascicular ventricular tachycardia).
Particular attention should be directed to those athletes with RV dysfunction, as they might occasionally fulfil criteria for ARVC diagnosis. Nevertheless, some athletes could develop incomplete forms of exerciseinduced, ARVC-like cardiomyopathy, particularly in the presence of complex ventricular arrhythmias and accompanying symptoms. The risk stratification schema in these cases is not well established. Athletes with potentially deleterious ventricular arrhythmias that originated in the right ventricle might present with a normal RV function at baseline, but show abnormalities in systolic function during a moderate-intensity exercise test 123 . An exercise test can also serve to unmask epsilon waves in individuals with underlying, clinically unapparent desmosome mutations 124 . The prevalence of gene-elusive (or exercise-induced) ARVC is unknown, but is probably very low, as previously discussed. Patients are commonly diagnosed in the third or fourth decade of life 10, 105, 106, 108 , and are likely to have experienced high-intensity, endurance training (such as marathon running and cycling) that has been sustained for years 10 . Furthermore, although no evidence sustains this hypothesis, genetic predisposition is likely to have an important role in these patients.
Therapeutic approach. The therapeutic approach for patients with RV arrhythmias is unclear. For those fulfilling ARVC criteria, well-established guidelines published by major scientific societies prohibit competitive sports (class I recommendation) and encourage avoidance of high-intensity dynamic sports in general (class IIa recommendation) 125, 126 . Deconditioning after an ARVC diagnosis has been suggested to delay the initiation of symptoms and reduce the cardiovascular complication rate 107 . The therapeutic approach for those athletes presenting with symptomatic ventricular arrhythmias and mild RV dilatation that are not diagnostic of ARVC is also uncertain. Radiofrecuency ablation should be performed if RV outflow idiopathic tachycardia cannot be reasonably ruled out. In any case, a close follow-up and a clinical approach similar to that for patients with ARVC seem prudent. Bradyarrhythmias and conduction blocks In contrast to exercise-induced tachyarrhythmias, the occurrence of bradyarrhythmias and conduction blocks in athletes has been recognized for decades, particularly sinus bradycardia and different degrees of atrioventricular block. Sinus bradycardia occurs frequently in athletes and, in conjunction with eccentric LV hypertrophy, provides some cardiac output reserve that helps to supply the high metabolic demands during exercise. Overall, sinus bradycardia at rest (with a heart rate of 30-60 bpm) is found in 50-80% of athletes 127, 128 and might occasionally be associated with long (>3 s) sinus pauses 129 . Although sinus bradycardia is an indisputable consequence of exercise, the causes of this condition remain unresolved. A reduction in heart rate could potentially result from changes in the autonomic tone (that is, an increase in the parasympathetic tone or a decreased sympathetic tone) or a reduction in intrinsic heart rate. Classic theories consider parasympathetic tone enhancement a critical driver of reduced heart rate, a process mediated by an increase in vagal nerve activity 130 and/or enhanced sensitivity of the heart to acetyl choline owing to the downregulation of regulatory G-protein signalling 58 . Nevertheless, this long-accepted notion has been challenged in the past few years by studies showing that the intrinsic heart rate (that is, heart rate in the absence of autonomic tone drivers) is lower in athletes than in seden tary individuals 131, 132 . Studies in animal models support this hypothesis and suggest that potassium/sodium hyperpolarizationactivated cyclic nucleotide-gated channel 4 (HCN4) downregulation in the sinus node and a decrease in the resulting I f current can be the basis for these changes 133 . Whether both mechanisms simul taneously coexist or drive heart rate in different settings or sporting activities remains unknown.
Delayed conduction in the atrioventricular node characteristically manifests in athletes as a first degree (that is, PR interval >200 ms) or a type I second degree atrioventricular block (Wenckebach block). Case reports on high-grade atrioventricular blocks potentially related to endurance training are infrequent and controversial, and this condition should not be considered as a normal feature of the athlete's heart 134 . As for sinus brady cardia, recent insights challenge the classic view that parasympathetic enhancement controls the delayed atrioventricular node conduction 132 . However, no consistent evidence exists showing that structural (that is, fibrosis or connexin redistrib ution) or primarily electrical disturbances underlie PR prolongation in athletes.
Sinus bradycardia and atrioventricular block have been considered as physiological changes secondary to long-term physical activity on the basis of generally favourable outcomes, a very low association with structural heart disease, and a low incidence of symptoms. Physiological exercise-induced bradyarrhythmias and blocks will become more evident in settings with parasympathetic predominance (such as during sleep) and disappear during exercise. However, even if bradycardia is reversible after deconditioning 104, 135 , former athletes will still present with a lower heart rate than sedentary age-matched individuals 19 , owing to persistent exerciseinduced changes. Certain degrees of irreversible sinus node dysfunction and atrioventircular block are likely to explain the (still controversial) high rate of pacemaker implantation in veteran athletes 19 . Therapeutic approach. Most sport-associated bradycardias in athletes remain asymptomatic. Only a minority of patients, particularly those with exaggerated sinus bradycardia or long pauses, present with symptoms, generally in the form of fatigue, dizziness, or even syncope 129, 136 . Most asymptomatic patients with exercise-induced bradyarrhythmias do not require any specific therapy; only those with extreme forms (for example, brady cardia <30 bpm or PR intervals >300 ms) require additional assessment 137 . Abandoning exercise or reducing the intensity or duration of physical activity might improve symptoms in those athletes with exercise-induced, symptomatic bradycardia or atrioventricualr blocks.
Pacemaker implantation should be indicated following standard guidelines 137, 138 . If a pacemaker is implanted, contact sports should be avoided in pacemaker-dependent patients, but could be allowed in certain nondependent patients 137 .
Conclusions
The causal role of strenuous exercise in AF epidemiology is now well-accepted, particularly for certain populations of well-trained individuals. The role of exercise as a central aetiological factor in ARVC is much more controversial, and largely dependent on a combin ation of exercise and genetic background. Nevertheless, both Nature Reviews | Cardiology
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Rule out underlying structural heart disease Furthermore, can we provide a personalized approach for the treatment of these arrhythmias? Our understanding of the mechanisms underlying these arrhythmias is incomplete, and are largely derived from animal models. This lack of understanding is further complicated in the case of RV arrhythmias, in which the genetic susceptibility of the individual seems to be critical and overlaps with relatively well-known hereditary conditions such as ARVC. The aim to undertake a personalized approach 139 should foster research into the mechanisms of these arrhythmias occurring in young, otherwise healthy individ uals to allow the establishment of primary prevention or effective early diagnostic strategies that are based on the underlying substrate.
Finally, do exercise-induced AF and ARVC have anything in common? Currently, we do not have any clinical evidence linking an exercise-induced atrial to RV arrhythmogenic substrate from an epidemiological point of view. Although some of the mechanisms involving haemodynamic overload, increased wall stress, and genetic susceptibility are likely to be coincident, further work is needed to understand the differences.
